ATS 2021: Tezepelumab Reduces Exacerbations in Oral Corticosteroid-dependent Patients with Severe Asthma
ATS 2021: In a subgroup of oral corticosteroid-dependent patients with severe asthma from the newly released NAVIGATOR study, tezepelumab reduced exacerbations and improved lung function.
ATS.2021: Study Finds Odds of Uncontrolled Asthma Increase with Higher Pandemic-related Stress
ATS.2021: Odds of uncontrolled asthma in response to pandemic-related stress increased in a significant dose-response manner among adult respondents to a new survey.
ACC.21: Prediabetes Significantly Increases Risk for MACE, According to New Findings
ACC.21: Findings from a study released in advance of the ACC annual meeting suggest that prediabetes confers nearly twice the risk of major cardiovascular events vs normoglycemia.
ATS.2021: At-risk Asthma Phenotypes Defined Using 4 Simple Metrics
ATS.2021. Study authors categorized asthma patients using age at onset, T2 biomarkers, and IL-6 levels, creating 12 phenotypes for additional study.
ATS 2021: Severe COPD Exacerbations May be Associated with Increased Mortality Risk
ATS 2021: The risk of morbidity and death in patients with COPD increases among those with moderate exacerbation, and even more so for severe exacerbation, new research suggests.
ATS 2021: Researchers Project Burden of COPD Will be Worse in 2050, Especially in US
In an abstract being presenting at the upcoming ATS 2021 International Conference, researchers estimate that by 2050 the US will lead the Americas in prevalence of COPD.
Black Women at Risk Early in Life for Future Cardiovascular Disease
ACC.21: High rates of obesity, hypertension, and hyperlipidemia found in Black women in their 20s and 30s are of significant concern, says the author of a study to be presented at the ACC meeting.
ATS 2021: Triple Combination Therapy May Benefit “Wide Spectrum” of Patients with COPD
American Thoracic Society 2021 International Conference: In a subset of patients from the ETHOS study, triple combination therapy was found beneficial for those with moderate COPD.
ACP: Lessons Learned during COVID-19 Pandemic
CDC Director Rochelle Walensky, MD MPH, was a featured presenter at the recent ACP Internal Medicine Meeting 2021: Virtual Experience, where she spoke about lessons learned during COVID-19.
ACP: Clyde Yancy, MD, MSc Reviews Advances in Heart Failure Research and Treatment
ACP: Clyde W Yancy, MD, gave a comprehensive update on a year's worth of pivotal science in treatment of heart failure. Here are the highlights.
Fauci: Widespread COVID-19 Vaccination, Precautions Key to Ending Pandemic
The NIAID head said the timing of the end of the pandemic is really up to the public.
Early Intervention in Weight Management: Treating Pre-Obesity
Research shows that increased risk of chronic disease and mortality begins below a BMI classified as obesity. The earlier we intervene with at-risk patients, the greater the chance for success.
A Weight-centric Approach to Obesity with T2D: How Pharmacotherapy Works
For frontline clinicians who care daily for patients with obesity and type 2 diabetes, a weight-centric approach to T2D, including antiobesity drugs, could help improve outcomes.
These Two Words Could Change Obesity Treatment, says Harold Bays, MD
Long time cardiometabolic investigator Harold Bays, MD, talks about obesity, new drugs to treat the disease, and how the words "be inefficient" could change thinking about treatment.
Starting a Dialogue about Obesity in Primary Care: Respect is Key
Primary care physicians face unique challenges when managing patients with obesity, but one obesity specialist aims to show clinicians how to meet them, even if it's in small ways.
Obesity Expert Discusses an Unexpected Metabolic Response to Weight Loss
Citing a study of "The Biggest Loser" participants, obesity expert Dr Silvana Pannain explains why "Eat less, exercise more," often backfires as a sole intervention for persons with obesity.
Keith C. Ferdinand, MD: COVID-19, Obesity, and the African American Community
Keith C Ferdinand, MD, discusses how deeply-rooted social determinants of health have led to the vastly disproportionate impact of COVID-19 on persons of color.
Guideline-directed Osteoporosis Treatment Found in Decline
ENDO 2021: Fewer than 1-in-10 older adults with a hip fracture had been prescribed bone-directed treatment in the 6 months prior to the incident, according to research on trends in treatment.
Dapagliflozin Effective in T2D with HFrEF Regardless of Type of Background T2D Therapy
VIDEO: Kieran Docherty, MBChB, discusses results of the DAPA-HF analysis on the impact of background T2D therapy on clinical outcomes in patients with T2D and HFrEF.
Glycemic Control in US Youth, Young Adults Disappointing
ADA 2020. Average A1c for a recent young cohort with type 2 diabetes was 8.5%, according to research presented at the ADA Virtual Scientific Sessions.
2 Clarke Drive Cranbury, NJ 08512